W
Wan-Ling Tan
Researcher at National Center for Charitable Statistics
Publications - 23
Citations - 262
Wan-Ling Tan is an academic researcher from National Center for Charitable Statistics. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 8 publications receiving 204 citations.
Papers
More filters
Journal ArticleDOI
Novel therapeutic targets on the horizon for lung cancer.
Wan-Ling Tan,Amit Jain,Angela Takano,Evan W. Newell,N. Gopalakrishna Iyer,Wan-Teck Lim,Wan-Teck Lim,Eng Huat Tan,Weiwei Zhai,Axel M. Hillmer,Wai Leong Tam,Wai Leong Tam,Daniel Shao-Weng Tan +12 more
TL;DR: Novel therapeutic agents for lung cancer that are in early-stage development are discussed, and how prospective clinical trials and drug development may be shaped by a deeper understanding of this heterogeneous disease is discussed.
Journal ArticleDOI
Advances in systemic treatment for nasopharyngeal carcinoma
Wan-Ling Tan,Eng Huat Tan,Darren Wan-Teck Lim,Quan Sing Ng,Daniel Shao-Weng Tan,Amit Jain,Mei-Kim Ang +6 more
TL;DR: Research has been focused on development of EBV-targeted strategies such as vaccination or administration of cytotoxic T-cells directed towards EBV, as well as evaluation of immune checkpoint inhibition approaches.
Journal ArticleDOI
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
Wan-Ling Tan,Quan Sing Ng,Cindy Lim,Eng Huat Tan,Chee Keong Toh,Mei-Kim Ang,Ravindran Kanesvaran,Amit Jain,Daniel Shao-Weng Tan,Darren Wan-Teck Lim +9 more
TL;DR: In patients with advanced EGFRm+ NSCLC with BM+, initiating patients on afatinib 40 mg OD was associated with improved PFS compared to 30’smg OD, underscoring the potential importance of dose intensity in control of CNS disease.
Journal ArticleDOI
Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
B. Chua,Eng Huat Tan,D.W.-T. Lim,M.-K. Ang,Daniel Shao Weng Tan,Q.S. Ng,Ravindran Kanesvaran,A. Jain,Wan-Ling Tan,Chee Keong Toh,T. Rajasekaran +10 more
Journal ArticleDOI
266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939
H.-F. Kao,M.-K. Ang,Q.S. Ng,D.S.W. Tan,Wan-Ling Tan,T. Rajasekaran,A. Jain,B-C. Liao,Sze Huey Tan,E-H. Tan,N.G. Iyer,Melvin L.K. Chua,R.-L. Hong,D.W-T. Lim +13 more